AORT · Artivion Inc
United States · RS rating 11 · As of 2026-10-14
| Price | 21.53 USD |
|---|---|
| 1-day change | +0.8% |
| RS rating (overall / 1M / 3M / 12M) | 11 / 16 / 23 / 15 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 16 / 24 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | -61.5% |
| Sales growth Q/Q | +2.3% |
| Distance from 52-week high | +54.8% |
| Market cap (USD) | $1.8B |